Glioblastoma Clinical Trials in Columbia, SC

Glioblastoma Clinical Trials in Columbia, SC

View the best 10 glioblastoma medical studies in Columbia, South Carolina. Access promising new therapies by applying to a Columbia-based Glioblastoma clinical trial.

Trials in Columbia, South Carolina

Here are the top 10 medical studies for glioblastoma in Columbia, South Carolina

Michael Bask Gill, B Sc preview

Michael Bask Gill, B Sc

Last Reviewed: February 11th, 2025

Image of Children's Hospital of Alabama in Birmingham, United States.

Radiation Therapy

Radiation

Recruiting1 awardPhase 2
This trial studies how well dabrafenib and trametinib work after radiation therapy in children and young adults with a specific type of brain tumor. These drugs help stop tumor growth by blocking signals that tell the cells to multiply. Dabrafenib has been developed and tested extensively for a specific type of skin cancer, showing effectiveness both alone and when used with trametinib.
Image of Augusta University, Georgia Cancer Center in Augusta, United States.

Etoposide +3 More

Topoisomerase Inhibitor

Recruiting1 awardPhase 1
This trial tests a new treatment combining two drugs, ibrutinib and indoximod, with chemotherapy for young patients whose brain cancer has not responded to other treatments. The goal is to boost the immune system's ability to fight the cancer by blocking proteins that help cancer cells survive.
Image of Children's Hospital of Alabama in Birmingham, United States.

Temozolomide +2 More

Alkylating Agent

Recruiting1 awardPhase 2
This trial is studying a combination of drugs as a potential treatment for newly diagnosed malignant glioma. The drugs being studied are veliparib, radiation therapy, and temozolomide.
Image of Grandview Cancer Center in Birmingham, United States.

OptuneĀ®

Device

Recruiting1 award12 criteria
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Image of Kaiser Permanente Los Angeles Medical Center in Los Angeles, United States.

Ramipril

ACE Inhibitor

Recruiting1 awardPhase 2
This trial is testing whether Ramipril can help cancer patients undergoing chemoradiation treatment by reducing memory loss. Patients will take the drug throughout treatment and for four months after. Memory will be assessed using neurocognitive tests.
Image of Banner MD Anderson in Gilbert, United States.

APL-101

Small Molecule Inhibitor

Recruiting1 awardPhase 2
This trial is testing APL-101, a new drug, on patients with specific genetic changes in their cancer. These patients often don't respond to typical treatments. The drug aims to block a protein that helps cancer cells grow and spread.
Image of 1004 in Denver, United States.

BDTX-1535

Small Molecule Inhibitor

Recruiting1 awardPhase 1 & 2
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Photon Beam Radiation Therapy +2 More

Radiation Therapy

Recruiting1 awardPhase 2
This trial is studying how well two types of radiation therapy work compared to standard radiation therapy when given with temozolomide in patients with newly diagnosed glioblastoma.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Temozolomide

Alkylating agents

Recruiting0 awardsPhase 2 & 3
This trial is studying the combination of temozolomide and veliparib compared to temozolomide alone in treating patients with newly diagnosed glioblastoma multiforme.
Image of Centralia Oncology Clinic in Centralia, United States.

Lomustine +2 More

Alkylating agents

Recruiting2 awardsPhase 3
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.

Popular Filters

Age 65+
Phase 3
< 50 mile distance
No Placebo

Trials With No Placebo

Denver, Colorado

Small Molecule Inhibitor

BDTX-1535 + Temozolomide for Glioblastoma and Lung Cancer

Recruiting1 awardPhase 1 & 2
Greenville, South Carolina
This trial is testing a new drug for people with glioblastoma or non-small cell lung cancer who have disease progression following standard of care.
Augusta, Georgia

Topoisomerase Inhibitor

Chemo-immunotherapy for Pediatric Brain Cancer

Recruiting1 awardPhase 1
Augusta, Georgia
This trial tests a new treatment combining two drugs, ibrutinib and indoximod, with chemotherapy for young patients whose brain cancer has not responded to other treatments. The goal is to boost the immune system's ability to fight the cancer by blocking proteins that help cancer cells survive.
Centralia, Illinois

Alkylating agents

Lomustine + Standard Therapy for Glioblastoma

Recruiting2 awardsPhase 3
Baltimore, Maryland
This trial is comparing the effect of adding lomustine to temozolomide and radiation therapy versus temozolomide and radiation therapy alone in treating newly diagnosed MGMT methylated glioblastoma.
Grand Rapids, Michigan

Monoclonal Antibodies

NGM707 + Pembrolizumab for Cancer

Recruiting1 awardPhase 1 & 2
Greenville, South Carolina
This trial is testing a new drug called NGM707, both by itself and with another drug, Pembrolizumab. It targets patients with very advanced or spreading solid tumors. The treatment aims to boost the immune system to better fight cancer.
Birmingham, Alabama

Device

Optune + Radiation & Chemotherapy for Brain Cancer

Recruiting1 award12 criteria
Charlotte, North Carolina
This trial is testing a new treatment for brain cancer that combines Optune with radiation and chemotherapy. The goal is to see if this new combination is more effective and has fewer side effects than current treatments.
Augusta, Georgia

Topoisomerase Inhibitor

Indoximod + Chemotherapy/Radiation for Pediatric Brain Cancer

Recruiting1 awardPhase 2
Augusta, Georgia
This trial is testing whether adding indoximod to chemotherapy and/or radiation improves outcomes for pediatric brain cancer patients.

View more glioblastoma clinical trials columbia

See more medical studies focusing on glioblastoma columbia

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' ā€” so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back ā€” in general, verified trials respond to patients within a few days.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top